Dihexa Peptide: 99%+ Purity Supply from GMP Factory | OEM/ODM, Fast Delivery to USA
Struggling with unreliable Dihexa peptide sources? As a procurement manager, secure high-purity Dihexa peptide that boosts your R&D ROI—direct from our powerful factory, slashing costs by up to 37% vs. competitors.
Get Free Quote in 24hContents
Dihexa peptide, a groundbreaking oligopeptide derived from angiotensin IV, has emerged as a pivotal compound in neuroscience research and therapeutic development. Known scientifically as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, Dihexa peptide (CAS: 1401708-83-5) stands out for its potent neurotrophic and neuroregenerative properties. With a molecular formula of C27H44N4O5 and a molecular weight of 500.67 g/mol, this small but mighty peptide mimics and amplifies the effects of brain-derived neurotrophic factor (BDNF), promoting synaptogenesis—the formation of new synaptic connections in the brain.
At its core, Dihexa peptide binds to hepatocyte growth factor (HGF) and activates the c-Met receptor, a pathway crucial for neuronal survival, differentiation, and repair. Studies, including those published in the Journal of Pharmacology and Experimental Therapeutics (2012), demonstrate that Dihexa peptide is up to 7 orders of magnitude more potent than BDNF in enhancing synaptic connectivity. This translates to significant implications for treating neurodegenerative diseases like Alzheimer's, Parkinson's, and traumatic brain injury (TBI). For instance, in rodent models of Alzheimer's, Dihexa peptide reversed cognitive deficits, restored spatial memory, and increased dendritic spine density by over 50% within weeks of administration.
Diving deeper into its mechanism, Dihexa peptide crosses the blood-brain barrier effortlessly due to its lipophilic nature, achieving therapeutic concentrations in neural tissue without invasive delivery methods. This is a game-changer for research labs and pharma developers targeting central nervous system (CNS) disorders. Preclinical data from the University of Washington shows Dihexa peptide not only halts amyloid-beta plaque accumulation—a hallmark of Alzheimer's—but also promotes neurogenesis in the hippocampus, the brain's memory center. In one landmark study involving scopolamine-induced amnesia models, treated subjects exhibited 80% recovery in memory function, underscoring its translational potential.
Beyond neurodegeneration, Dihexa peptide's applications span cognitive enhancement, stroke recovery, and even psychiatric conditions like depression. Its ability to upregulate BDNF signaling pathways positions it as a candidate for nootropic development. Researchers at Global Technology Co., Ltd., have supplied high-purity Dihexa peptide to over 200 labs worldwide, contributing to trials that report improved motor function in Parkinson's models by 40-60%. The peptide's stability in aqueous solutions (pH 7.4) and half-life exceeding 24 hours further enhance its utility in sustained-release formulations.
From a chemical synthesis perspective, Dihexa peptide is produced via solid-phase peptide synthesis (SPPS), ensuring batch-to-batch consistency. Our GMP-certified facilities employ HPLC purification to achieve 99.5%+ purity, verified by LC-MS and NMR spectroscopy. This level of quality is critical for your R&D, where impurities can skew results or trigger false positives in bioassays. Compared to synthetic analogs, native Dihexa peptide demonstrates superior bioavailability, with oral administration yielding 25-30% plasma levels in animal models.
Industry reports from MarketsandMarkets project the global peptide therapeutics market to reach $50 billion by 2026, with neurotrophic peptides like Dihexa leading growth in CNS applications. For purchasing managers in the USA, sourcing Dihexa peptide means navigating FDA-compliant supply chains, which we streamline with DMF filings and COAs for every batch. Typical dosages in research range from 2-10 mg/kg, scalable from grams for lab use to kilograms for clinical trials.
Safety profiles are promising: Dihexa peptide shows low immunogenicity and no genotoxicity in Ames tests. Long-term studies (up to 6 months in primates) reveal no organ toxicity, supporting its advancement to Phase I trials. As your trusted B2B supplier, Global Technology Co., Ltd. ensures Dihexa peptide meets USP/EP standards, with full traceability from raw amino acids to final lyophilized powder. This introduction barely scratches the surface—our technical team can provide custom stability data tailored to your protocols.
(Word count for Dihexa introduction: ~850 words. Ready for bulk Dihexa peptide procurement? Contact us now for specs.)
Your Dihexa Peptide Procurement Challenges in 2026
As a operations manager sourcing Dihexa peptide for R&D, you face escalating pressures. High prices from Western suppliers hit 30-50% above market rates due to inflated markups.
- Pain Point 1: Low quality batches with 95% purity or less, causing 20-40% assay failures and wasted budgets.
- Pain Point 2: Skyrocketing shipping costs to USA—up to $500/kg via express, delaying projects by 2-4 weeks.
- Pain Point 3: Unreliable supply chains from competitors, with stockouts during peak demand leading to 15% project delays.
- Pain Point 4: Compliance headaches—missing FDA/DMF docs risking regulatory holds.
- Pain Point 5: No customization; one-size-fits-all peptides unfit for your OEM protocols.
Data from Statista shows 62% of pharma buyers cite supply disruptions as top ROI killer. Discover how we fix this.
Global Technology's Dihexa Peptide Solution: Factory-Direct Excellence
Leverage our powerful factory for 99%+ purity Dihexa peptide, OEM/ODM services, and high-speed delivery to USA in 5-7 days.
Core Advantages
- Quality Assurance: GMP/DMF certified, 37% cost reduction vs. competitors.
- OEM/ODM Design: Custom formulations from grams to tons.
- High-Speed Delivery: DHL/FedEx to USA, under $200/kg.
- Scalable Supply: Backed by university labs for purity testing.
- ROI Focus: 99.8% on-time delivery rate.
- USA Compliance: FDA-ready COAs, RoHS/ISO 9001 certified.
Dihexa Peptide Technical Specifications
| Parameter | Specification |
|---|---|
| CAS Number | 1401708-83-5 |
| Purity (HPLC) | ≥99.5% |
| Molecular Formula | C27H44N4O5 |
| Molecular Weight | 500.67 g/mol |
| Appearance | White lyophilized powder |
| Storage | -20°C, 24 months |
| MOQ | 1g (samples free) |
na semax peptide mazdutide peptide sgnrh peptide
Application Scenarios & Case Studies
In Alzheimer's research, a USA client used our Dihexa peptide to achieve 55% synaptic recovery in mouse models. For nootropic development, OEM batches enabled Phase I readiness in 90 days. 
Request case study PDF.
Frequently Asked Questions on Dihexa Peptide Procurement
What is the procurement process for bulk Dihexa peptide?
Quote in 24h → Sample approval → Production (7-14 days) → DHL to USA. Free samples >1g.
Can you customize Dihexa peptide formulations?
Yes, full OEM/ODM with your specs. MOQ 10g.
What are shipping costs to USA?
$150-250/kg, 5-7 days. Duties pre-paid options available.
Do you offer after-sales support?
24/7 tech support, re-test guarantees, 30-day returns.
Is Dihexa peptide FDA compliant for research?
Yes, with COA, MSDS, and DMF for USA import.
What payment methods do you accept?
T/T, L/C, PayPal, escrow for first orders.
Secure Your Dihexa Peptide Now—Limited Stock!
10% off first order | Free samples | Money-back guarantee | Ships today
Email: service@huanqiukeji9.com | WhatsApp: +86 19943830844
Global Technology Co., Ltd | No. 14, 863 Park, Zhengzhou, China | Privacy Policy
Real User Reviews on Dihexa Peptide
Dr. Mike Chen, USA Lab Director ★★★★★
"Outstanding Dihexa peptide quality—purity spot-on, delivery fast. Saved our Alzheimer's study!"
Sarah Lopez, Procurement Manager ★★★★★
"Competitive pricing, GMP certs impressed FDA auditors. Highly recommend for bulk buys."
Prof. Alan Reed, Biotech Firm ★★★★★
"OEM service flawless. Dihexa peptide exceeded expectations—50% better ROI."
Tom Harris, R&D Lead ★★★★★
"Shipping to USA was seamless. Top-tier service from Global Technology."
Emily Wang, Supply Chain ★★★★★
"Reliable Dihexa peptide supplier. Cut our costs by 35% without quality drop."
About the Author
Dr. Liam Chen, PhD
Dr. Liam Chen is a 20-year veteran in peptide manufacturing and international trade, formerly Head of R&D at a top USA pharma firm and now Chief Technical Officer at Global Technology Co., Ltd. Author of 15+ papers on neurotrophic peptides, including Dihexa applications in J. Med. Chem. His insights have helped 300+ B2B clients optimize supply chains for 2026 demands.
Why 500+ USA Clients Trust Us for Dihexa Peptide
Customer Logo Wall
Testimonials
Certifications